(NASDAQ: QDEL) Quidelortho's forecast annual revenue growth rate of 4.79% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.64%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.12%.
Quidelortho's revenue in 2026 is $2,657,200,000.On average, 10 Wall Street analysts forecast QDEL's revenue for 2026 to be $192,707,734,914, with the lowest QDEL revenue forecast at $183,774,715,355, and the highest QDEL revenue forecast at $199,185,878,869. On average, 10 Wall Street analysts forecast QDEL's revenue for 2027 to be $200,140,552,715, with the lowest QDEL revenue forecast at $190,525,623,266, and the highest QDEL revenue forecast at $207,368,797,549.
In 2028, QDEL is forecast to generate $208,732,617,329 in revenue, with the lowest revenue forecast at $197,753,868,100 and the highest revenue forecast at $216,370,008,097.